mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.094 |
0.07 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.08 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.08 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.08 |